Wendell David Associates Inc / JNJ
Wendell David Associates Inc’s Johnson & Johnson Position
Does Wendell David Associates Inc own Johnson & Johnson (JNJ)? Yes — 100.7K shares worth $25M (+2.68% of its 13F portfolio) as of Q1 2026, up from 100.5K shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
100.7K
% of Portfolio
+2.68%
Quarters Held
29
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 100.7K | $25M | +2.68% |
| Q4 2025 | 100.5K | $21M | +2.11% |
| Q3 2025 | 103.8K | $19M | +1.90% |
| Q2 2025 | 103.8K | $16M | +1.60% |
| Q1 2025 | 105.3K | $17M | +1.74% |
| Q4 2024 | 110.9K | $16M | +1.59% |
| Q3 2024 | 112.3K | $18M | +1.74% |
| Q2 2024 | 114.3K | $17M | +1.70% |
| Q1 2024 | 114.2K | $18M | +1.83% |
| Q4 2023 | 114.5K | $18M | +1.93% |
| Q3 2023 | 115.1K | $18M | +2.11% |
| Q2 2023 | 108.8K | $18M | +2.03% |
| Q1 2023 | 108.9K | $17M | +2.00% |
| Q4 2022 | 108.3K | $19M | +2.35% |
| Q3 2022 | 108.8K | $18M | +2.39% |
| Q2 2022 | 108.9K | $19M | +2.46% |
| Q1 2022 | 109.2K | $19M | +2.15% |
| Q4 2021 | 110.1K | $19M | +1.91% |
| Q3 2021 | 110.2K | $18M | +1.98% |
| Q2 2021 | 109.9K | $18M | +2.03% |
| Q1 2021 | 108.8K | $18M | +2.15% |
| Q4 2020 | 108.5K | $17M | +2.09% |
| Q3 2020 | 109.6K | $16M | +2.17% |
| Q2 2020 | 112.3K | $16M | +2.29% |
| Q1 2020 | 114.1K | $15M | +2.53% |
| Q4 2019 | 114.7K | $17M | +2.30% |
| Q3 2019 | 117.6K | $15M | +2.23% |
| Q2 2019 | 117.2K | $16M | +2.45% |
| Q1 2019 | 118.2K | $17M | +2.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wendell David Associates Inc’s full portfolio or all institutional holders of JNJ.